Bonesupport Holding AB (publ)
Bonesupport Holding AB (publ)
Your view on BOEUF
Overview
What the company does, where it operates, and who runs it.
About Bonesupport Holding AB (publ)
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Torbjorn Skold
- Headquarters
- Scheelevägen 19, Lund, SE
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Torbjorn Skold
- Headquarters
- Scheelevägen 19, Lund, SE
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids in Europe, North America, and internationally.
The company provides CERAMENT Bone Void Filler, an injectable, moldable, and drillable synthetic bone void filler that includes hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol; CERAMENT G, a gentamicin injectable ceramic bone graft substitute; and CERAMENT V, a vancomycin injectable synthetic bone void filler.
It also develops preclinical product candidates to promote bone regrowth focusing on trauma, revision arthroplasty, chronic osteomyelitis, revision artroplasty, and oncology, as well as bone and foot infections due to diabetes. The company was founded in 1999 and is headquartered in Lund, Sweden.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Bonesupport Holding AB (publ), and the rating behind it. BOEUF last traded at $20.35, 67.3× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Bonesupport Holding AB (publ). Starting points for Bonesupport Holding AB (publ): P/E 67.3, EPS $3.25, beta 0.39 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Bonesupport Holding AB (publ). Bonesupport Holding AB (publ) does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Bonesupport Holding AB (publ). Trailing twelve-month EPS for Bonesupport Holding AB (publ) stands at $3.25. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Bonesupport Holding AB (publ). Bonesupport Holding AB (publ) has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Bonesupport Holding AB (publ) valued side by side against its closest peers. Bonesupport Holding AB (publ) is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Bonesupport Holding AB (publ), and how their positions are changing. At a $1.34B market value, institutional positions materially move Bonesupport Holding AB (publ)'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Bonesupport Holding AB (publ) executives and directors. Shares of Bonesupport Holding AB (publ) have traded between $18.57 and $35.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Bonesupport Holding AB (publ). Bonesupport Holding AB (publ) is a $1.34B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Bonesupport Holding AB (publ). Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Bonesupport Holding AB (publ). Coverage tracks Bonesupport Holding AB (publ) within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.